The Aurum Institute
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Charalambous, Salome
panTB-HM, NCT05686356: A Pan-TB Regimen Targeting Host and Microbe

Recruiting
2/3
352
RoW
Sutezolid, N-acetyl cysteine, NAC, Pretomanid, Bedaquiline, Rifafour
The Aurum Institute NPC, Ludwig-Maximilians - University of Munich, Stichting Katholieke Universiteit, Wits Health Consortium (Pty) Ltd, Instituto Nacional de Saúde, Mozambique, National Institute for Medical Research, Tanzania, University of Stellenbosch, Sequella, Inc., Global Alliance for TB Drug Development
Tuberculosis
09/25
09/25
SMARTT, NCT05017324 / 2020-004084-10: Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Recruiting
N/A
248
RoW
WGS DST strategy
Universiteit Antwerpen, Aurum Institute, University of Stellenbosch, University of the Free State, Free State Department of Health
Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, Multidrug Resistant Tuberculosis, Pulmonary Tuberculoses
12/22
01/25
NCT04494516: Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial

Completed
N/A
183
RoW
Johns Hopkins University, UNITAID, Aurum Institute, KNCV Tuberculosis Foundation
Tuberculosis Infection, Tuberculosis Prevention
06/23
06/23

Download Options